Literature DB >> 7603813

Eradication of poliomyelitis: progress in the People's Republic of China.

B Yang1, J Zhang, M W Otten, K Kusumoto, T Jiang, R Zhang, L Zhang, K A Wang.   

Abstract

China and the other countries of the Western Pacific Region have a goal of eradication of wild poliovirus by the end of 1995. In this report we examine the progress made toward eradication through the end of 1993. We examined the information about poliomyelitis and wild poliovirus based on the acute flaccid paralysis surveillance system. The number of reported poliomyelitis cases decreased from 4623 cases in 1989 and 5065 cases in 1990, which occurred during a large nationwide poliomyelitis epidemic, to 538 cases in 1993. Mass supplemental immunization sessions were conducted during the 1991 to 1992 and 1992 to 1993 winters. After the two rounds of supplemental immunizations in the 1992 to 1993 winter, wild poliovirus was not detected for the subsequent 21 months in 22 contiguous provinces in central and northern China, in which 980 million persons reside. In 1993 wild poliovirus was detected in only 5 provinces in southern China and in 2 provinces in the remote Western region; these provinces have only 14% of the total population in China. China is close to achieving its 1995 poliomyelitis elimination goal. Mass supplemental immunizations in children 0 to 3 years old can rapidly eliminate wild poliovirus from large, very densely populated areas, low income rural areas and remote mountainous areas. There appears to be no technical obstacle, even in the most difficult areas, to achieving global eradication of wild poliovirus by the year 2000.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7603813

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  6 in total

1.  Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China.

Authors:  H M Liu; D P Zheng; L B Zhang; M S Oberste; M A Pallansch; O M Kew
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Serial recombination during circulation of type 1 wild-vaccine recombinant polioviruses in China.

Authors:  Hong-Mei Liu; Du-Ping Zheng; Li-Bi Zhang; M Steven Oberste; Olen M Kew; Mark A Pallansch
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

3.  Trends in notifiable infectious diseases in China: implications for surveillance and population health policy.

Authors:  Lei Zhang; David P Wilson
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

4.  The second campaign for poliomyelitis vaccination in the eastern province: different strategy with similar success.

Authors:  A A Al-Sulaiman; Y Y Al-Mazrou; A A Al-Bar; A A Al-Ali
Journal:  J Family Community Med       Date:  1997-01

5.  Did the national campaign for poliomyelitis vaccination achieve its objectives? A pilot survey in Al-khobar area.

Authors:  A Ai-Sulaiman; Y Y Al-Mazrou; A Ai-Bar
Journal:  J Family Community Med       Date:  1996-07

6.  Isolation and Characterization of a Highly Mutated Chinese Isolate of Enterovirus B84 from a Patient with Acute Flaccid Paralysis.

Authors:  Huanying Zheng; Yong Zhang; Leng Liu; Jing Lu; Xue Guo; Hui Li; Hanri Zeng; Ling Fang; Wenbo Xu; Changwen Ke
Journal:  Sci Rep       Date:  2016-08-08       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.